MARIA LOPEZ: Open Payments
NPI 1124480751 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,350 in 12 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $504 · 2025 $1,350
Food & beverage: $1,350
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $250 |
| Novo Nordisk Inc | 2 | $246 |
| Lilly USA, LLC | 2 | $228 |
| Amgen Inc. | 1 | $146 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $122 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $120 |
| ACADIA Pharmaceuticals Inc | 2 | $118 |
Products named: REPATHA, UBRELVY, QULIPTA, Wegovy, REXULTI, Kerendia, Ozempic, ISTURISA.
Industry payments across TX — which companies pay providers there.
